Clinical Trial

Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention

Study acronym: EASE-PRM-PCI
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the effects of N-acetyl cysteine on major cardiac and cerebral events in patients undergoing primary percutaneous coronary intervention who have moderate to high risk for contrast induced nephropathy. In a sub-group of patients coronary flow reserve will be evaluated.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2013-06-12; most recent amendment 2025-05-17.
Status change: Recruiting → Active, Not Recruiting 2017-01-18
Trial Details
NCT Number NCT01878344
Lead Sponsor Suleyman Demirel University
Conditions Acute ST Segment Elevation Myocardial Infarction
Enrollment 100 participants
Start Date 2013-01
Primary Completion 2018-01 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-20